SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 305 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $8,000 | -11.1% | 118 | 0.0% | 0.00% | – |
Q1 2022 | $9,000 | -10.0% | 118 | 0.0% | 0.00% | – |
Q4 2021 | $10,000 | -9.1% | 118 | 0.0% | 0.00% | – |
Q3 2021 | $11,000 | +37.5% | 118 | 0.0% | 0.00% | – |
Q2 2021 | $8,000 | 0.0% | 118 | 0.0% | 0.00% | – |
Q1 2021 | $8,000 | 0.0% | 118 | 0.0% | 0.00% | – |
Q4 2020 | $8,000 | -50.0% | 118 | 0.0% | 0.00% | -100.0% |
Q3 2020 | $16,000 | +45.5% | 118 | +73.5% | 0.00% | 0.0% |
Q2 2020 | $11,000 | 0.0% | 68 | -42.4% | 0.00% | 0.0% |
Q1 2020 | $11,000 | -26.7% | 118 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $15,000 | +87.5% | 118 | 0.0% | 0.00% | – |
Q3 2019 | $8,000 | -52.9% | 118 | 0.0% | 0.00% | -100.0% |
Q2 2019 | $17,000 | +21.4% | 118 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $14,000 | -39.1% | 118 | -45.9% | 0.00% | -50.0% |
Q4 2018 | $23,000 | -34.3% | 218 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $35,000 | -32.7% | 218 | -45.2% | 0.00% | -50.0% |
Q2 2018 | $52,000 | +36.8% | 398 | -23.2% | 0.00% | +33.3% |
Q1 2018 | $38,000 | +533.3% | 518 | +339.0% | 0.00% | +200.0% |
Q4 2017 | $6,000 | +20.0% | 118 | 0.0% | 0.00% | – |
Q3 2017 | $5,000 | +66.7% | 118 | 0.0% | 0.00% | – |
Q2 2017 | $3,000 | -76.9% | 118 | -73.8% | 0.00% | -100.0% |
Q1 2017 | $13,000 | +160.0% | 451 | +124.4% | 0.00% | 0.0% |
Q4 2016 | $5,000 | -66.7% | 201 | -19.9% | 0.00% | -50.0% |
Q3 2016 | $15,000 | +150.0% | 251 | -16.6% | 0.00% | +100.0% |
Q2 2016 | $6,000 | +50.0% | 301 | +49.8% | 0.00% | 0.0% |
Q1 2016 | $4,000 | – | 201 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |